European Medicines Agency - Human Medicines - Orphan medicinal products - Summaries of opinion on orphan designation

Human medicines - Orphan medicinal products
Summaries of opinion on orphan designation
Please use the mail box to comment on summaries of opinion on orphan designation. Please note, however, that the EMEA will not answer individual e-mails received.

Note: Draft status is awarded to a title when the document is pending comments from patients' representative organisation


abrir aquí para acceder a la información específica sobre cada droga huérfana:
European Medicines Agency - Human Medicines - Orphan medicinal products - Summaries of opinion on orphan designation